https://doi.org/10.4081/hls.2024.12456
The amount of DNA and RNA in primary cancer cells and their metastases
Submitted: 5 March 2024
Accepted: 10 May 2024
Published: 22 August 2024
Accepted: 10 May 2024
Abstract Views: 90
PDF: 89
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Considering the significant impact of oncopathology on global morbidity and mortality, as well as changes in its prevalence and typology, research into the molecular-genetic mechanisms of oncogenesis and metastasis, particularly the role of nucleic acids, becomes crucial. The aim of this study is to determine the content of DNA and RNA in cells of primary cancer and its metastases through microspectrophotometric analysis of malignant cells collected from 30 patients with primary and metastatic oncological processes. The following methods were employed: microspectrophotometric analysis using the automated complex “Protva-PM11-DVK-3m,” staining of histological specimens with halo cyanin-chrome alum, the discrete statistics method, frequency and cluster analysis, and the bibliographic method. Changes in the concentration of nucleic acids in the cells of primary and metastatic tumors were identified during the study. The changes did not always correlate with each other, indicating morphofunctional polymorphism in tumor cell populations. A trend towards a decrease in nuclear RNA concentration and an increase in cytoplasmic RNA concentration in metastases were observed, suggesting alterations in metabolic and synthetic processes in cells and a decrease in their differentiation degree.
Sulaieva ON, Artamonova O, Dudin O, et al. Ethical navigation of biobanking establishment in Ukraine: Learning from the experience of developing countries. 2023. Available from: https://jme.bmj.com/content/early/2023/11/09/jme-2023-109129
DOI: https://doi.org/10.1136/jme-2023-109129
Bondarenko LB, Karatsuba TA, Khavich OO, et al. The effect of ethyl 2-(quinazolin-4-yl-amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate hydrochloride on DNA, RNA, chromatin proteins and contents of non-protein and protein-bounded SH-groups in rats’ sarcoma 45 and unchanged skin tissues. Pharmacol Drug Toxicol 2020;14:97-105.
Kirkilevskyi SI, Sulaeva OM, Lukyanchuk OV, et al. Immunoscore and personification of chemotherapeutic treatment in patients with gastric cancer. Ukr J Radiol Oncol 2020;28:199-207.
DOI: https://doi.org/10.46879/ukroj.3.2020.199-207
Dumanskyi YuV, Kirkilevskyi SI, Sulaeva OM, et al. Impact of tumor molecular phenotype on survival of patients with gastric cancer after radical surgery. Exp Oncol 2022;44:324-6.
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18903
Kulak MO. Prospects for the development of pharmaceuticals based on the mechanism of RNA interference. Kyiv: National Aviation University; 2020. Available from: https://er.nau.edu.ua/handle/NAU/46746
Zhang C, Zhao Y, Xu X, et al. Cancer diagnosis with DNA molecular computation. Nat Nanotechnol 2020;15:709-15.
DOI: https://doi.org/10.1038/s41565-020-0699-0
Aragon IM, Cendón Y, Lorente D, et al. Implications of single nucleotide polymorphisms (SNPs) in androgen related-genes in outcome of metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone (Abi) and enzalutamide (Enza). Ann Oncol 2019;30:v346.
DOI: https://doi.org/10.1093/annonc/mdz248.038
Schulz M, Salamero-Boix A, Niesel K, et al. Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis. Front Immunol 2019;10:1713.
DOI: https://doi.org/10.3389/fimmu.2019.01713
Chulenbayeva L, Ilderbayev O, Taldykbayev Z, et al. Phytocorrection of immunological and biochemical changes in the combined impact of coal dust and high dose of radiation. Georgian Med News 2018;1:141-50.
Shen Z, Ma Q, Zhou X, et al. Strategies to improve photodynamic therapy efficacy by relieving the tumor hypoxia environment. NPG Asia Mater 2021;13:39.
DOI: https://doi.org/10.1038/s41427-021-00303-1
Sevastre AS, Manea EV, Popescu OS, et al. Intracellular pathways and mechanisms of colored secondary metabolites in cancer therapy. Int J Mol Sci 2022;23:9943.
DOI: https://doi.org/10.3390/ijms23179943
Hussain S, Afzal O, Gupta G, et al. Long non-coding RNAs in lung cancer: unraveling the molecular modulators of MAPK signaling. Pathol Res Pract 2023;249:154738.
DOI: https://doi.org/10.1016/j.prp.2023.154738
Dykstra PB, Kaplan M, Smolke CD. Engineering synthetic RNA devices for cell control. Nat Rev Genet 2022;23:215-28.
DOI: https://doi.org/10.1038/s41576-021-00436-7
Epum EA, Haber JE. DNA replication: the recombination connection. Trends Cell Biol 2022;32:45-57.
DOI: https://doi.org/10.1016/j.tcb.2021.07.005
Khavinson VK, Popovich IG, Linkova NS, et al. Peptide regulation of gene expression: a systematic review. Molecules 2021;26:7053.
DOI: https://doi.org/10.3390/molecules26227053
Svyatova G, Berezina G, Urazbayeva G, Murtazaliyeva A. Frequencies of diagnostically significant polymorphisms of hereditary breast cancer forms in BRCA1 and BRCA2 genes in the Kazakh population. Asian Pacif J Cancer Prev 2023;24:3899-907.
DOI: https://doi.org/10.31557/APJCP.2023.24.11.3899
Feunteun J, Ostyn P, Delaloge S. Tumor cell malignancy: a complex trait built through reciprocal interactions between tumors and tissue-body system. iScience 2022;25:104217.
DOI: https://doi.org/10.1016/j.isci.2022.104217
Li J, Chen D, Shen M. Tumor microenvironment shapes colorectal cancer progression, metastasis, and treatment responses. Front Med 2022;9:869010.
DOI: https://doi.org/10.3389/fmed.2022.869010
Altayeva AA, Issenova SS, Machtejeviene E, et al. Results of using the Robson classification in Kazakhstan. Open Access Macedonian Journal of Medical Sciences 2021;9:663-9.
DOI: https://doi.org/10.3889/oamjms.2021.6398
Pappuswamy M, Chaudhary A, Meyyazhagan A, et al. DNA damage on buccal epithelial cells, personal working in the rubber industry occupationally exposed to carbon disulfide (CS2). Asian Pacif J Cancer Prev 2023;24:357-61.
DOI: https://doi.org/10.31557/APJCP.2023.24.2.357
Salimi M, Rastegarpouyani S. E74-like factor 5 promoter methylation in circulating tumor DNA as a potential prognostic marker in breast cancer patients. Asian Pacif J Cancer Prev 2023;24:4035-41.
DOI: https://doi.org/10.31557/APJCP.2023.24.12.4035
Fu LQ, Du WL, Cai MH, et al. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol 2020;353:104119.
DOI: https://doi.org/10.1016/j.cellimm.2020.104119
Abdi E, Latifi-Navid S. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer. Pathol Res Pract 2022;239:154165.
DOI: https://doi.org/10.1016/j.prp.2022.154165
Hirna HA, Maltsev DV, Natrus LV, et al. Study of the immunomodulating influence of preparation alpha/beta-defensins on chemo/radiotherapy of patients with oral and oropharyngeal cancer. Fiziologich Zhurn 2021;67:86-96.
DOI: https://doi.org/10.15407/fz67.04.086
Mazziotta C, Lanzillotti C, Iaquinta MR, et al. MicroRNAs modulate signalling pathways in osteogenic differentiation of mesenchymal stem cells. Int J Mol Sci 2021;22:2362.
DOI: https://doi.org/10.3390/ijms22052362
How to Cite
Herasymenko, O., Gerasymenko, K., & Herasymenko, O. (2024). The amount of DNA and RNA in primary cancer cells and their metastases. Healthcare in Low-Resource Settings. https://doi.org/10.4081/hls.2024.12456
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.